Learn more at LeadIQ.com

Insights

mRNA Vaccine Development BioNTech is actively developing mRNA vaccine candidates for a range of infectious diseases, presenting opportunities for partnerships and collaborations within the healthcare sector.

Capacity for Public Health Emergencies Through its agreement to dedicate manufacturing capacity for mRNA vaccines during public health emergencies, BioNTech showcases readiness for rapid response opportunities in crisis situations.

Legal Challenges and Patent Disputes Navigating legal challenges and patent disputes related to COVID-19 vaccines, BioNTech may seek legal counsel services or partnerships to address and mitigate potential risks.

Strategic Hiring of Key Executives Recent appointments of a chief commercial officer and chief legal officer highlight BioNTech's commitment to strengthening its leadership team to drive business growth and expansion efforts.

Competitive Positioning in Biotechnology Research As a key player in biotechnology research with a focus on mRNA-based therapies, BioNTech presents itself as a competitive partner for organizations looking to leverage cutting-edge advancements in healthcare solutions.

Similar companies to BioNTech SE

BioNTech SE Tech Stack

BioNTech SE uses 8 technology products and services including QlikView, Zendesk, IBM Watson, and more. Explore BioNTech SE's tech stack below.

QlikView
Business Intelligence
Zendesk
Documentation Tools
IBM Watson
IT Infrastructure
UNIX
Operating Systems
Pantheon
Platform As A Service
Yoast SEO
Search Engines
Base SAS
Software As A Service
Twitter
Widgets

Media & News

BioNTech SE's Email Address Formats

BioNTech SE uses at least 1 format(s):

BioNTech SE Email Formats	Example	Percentage
First.Last@biontech.de	John.Doe@biontech.de	94%
FLast@biontech.de	JDoe@biontech.de	4%
First.Middle@biontech.de	John.Michael@biontech.de	1%
Last.First@biontech.de	Doe.John@biontech.de	1%

Frequently Asked Questions

Where is BioNTech SE's headquarters located?

BioNTech SE's main headquarters is located at An der Goldgrube 12 Mainz, Rhineland-Palatinate 55131 DE. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is BioNTech SE's phone number?

You can contact BioNTech SE's main corporate office by phone at

+49-6131-9****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioNTech SE's stock symbol?

BioNTech SE is a publicly traded company; the company's stock symbol is BNTX.

What is BioNTech SE's official website and social media links?

BioNTech SE's official website is biontech.de and has social profiles on LinkedIn.

How much revenue does BioNTech SE generate?

As of November 2024, BioNTech SE's annual revenue reached $18B.

What is BioNTech SE's SIC code NAICS code?

BioNTech SE's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioNTech SE have currently?

As of November 2024, BioNTech SE has approximately 4.9K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer & Co-Founder: U. S.Chief Operating Officer: S. P.Chief Financial Officer: J. H.. Explore BioNTech SE's employee directory with LeadIQ.

What industry does BioNTech SE belong to?

BioNTech SE operates in the Biotechnology Research industry.

What technology does BioNTech SE use?

BioNTech SE's tech stack includes QlikViewZendeskIBM WatsonUNIXPantheonYoast SEOBase SASTwitter.

What is BioNTech SE's email format?

BioNTech SE's email format typically follows the pattern of . Find more BioNTech SE email formats with LeadIQ.

How much funding has BioNTech SE raised to date?

As of November 2024, BioNTech SE has raised $145M in funding. The last funding round occurred on May 29, 2024 for $145M.

When was BioNTech SE founded?

BioNTech SE was founded in 2008.

BioNTech SE

BioNTech SE

Biotechnology ResearchRhineland-Palatinate, Germany1001-5000 Employees

BioNTech is a global next generation immunotherapy company aspiring to translate science into survival. Around 6.100 pioneers currently work with us, employing a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Our broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor (CAR) T cells, several protein-based therapeutics, including bispecific immune checkpoint modulators, targeted cancer antibodies and antibody-drug conjugate (ADC) therapeutics, as well as small molecules. 
  
Based on our deep expertise in mRNA vaccine development and in-house manufacturing capabilities, we are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. 

To learn more about us, please visit www.BioNTech.com. 

Our privacy statement can be found here:  https://www.biontech.com/int/en/home/data-privacy-statement.html 

Our imprint can be found:
https://www.biontech.com/int/en/home/imprint.html

Company Overview

Headquarters: An der Goldgrube 12 Mainz, Rhineland-Palatinate 55131 DE
Phone number: +49-6131-9****
Website: biontech.de
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: BNTX
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2008
Employees: 1001-5000

Media & News

Funding & Financials

$145M
BioNTech SE has raised a total of $145M of funding over 10 rounds. Their latest funding round was raised on May 29, 2024 in the amount of $145M.
$1B
BioNTech SE's revenue is in the range of $1B

Funding & Financials

$145M
BioNTech SE has raised a total of $145M of funding over 10 rounds. Their latest funding round was raised on May 29, 2024 in the amount of $145M.
$1B
BioNTech SE's revenue is in the range of $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.